# Evaluation of Long-Acting Muscarinic Antagonists in COPD

> **NCT02039050** · PHASE4 · COMPLETED · sponsor: **University of Dundee** · enrollment: 15 (actual)

## Conditions studied

- Pulmonary Disease, Chronic Obstructive

## Interventions

- **DRUG:** Tiotropium
- **DRUG:** Aclidinium

## Key facts

- **NCT ID:** NCT02039050
- **Lead sponsor:** University of Dundee
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-02
- **Primary completion:** 2015-07
- **Final completion:** 2015-07
- **Target enrollment:** 15 (ACTUAL)
- **Last updated:** 2019-04-12

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02039050

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02039050, "Evaluation of Long-Acting Muscarinic Antagonists in COPD". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02039050. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*